Investment & Licensing

Selected patent assets. Serious conversations.

Hypha Labs is opening qualified conversations around selected patent assets and draft term sheets. We work directly with investors, operators, OEMs, and licensing teams exploring a focused path into the portfolio.

Discuss an Opportunity Review the Patent Portfolio
Public portfolio overview

A portfolio organized around durable technology areas.

The public record is intentionally concise. The overview below follows the categories and filing/status language in the full portfolio, so prospective partners can identify a fit before requesting a direct review.

Biological Materials

Patent-pending biological materials work with additional disclosures in preparation.

Whale Oil Wax Esters: Bio-derived Structural Thermoset Polymers Patent Pending · App. 64/055,368 · Filed 2025
Additional technology disclosures Patent Pending · Technology Disclosure in Preparation · Details available upon qualified inquiry.

Advanced Propulsion

A set of patent-pending filings represented publicly at the technology-disclosure level.

Advanced Propulsion portfolio 10 filings · Patent Pending · Technology Disclosure in Preparation
Public-safe review posture Details available upon qualified inquiry.

Other Technologies

Selected assets with distinct investor, licensing, and acquisition entry points.

Split-Witness Memory-Scalable Zero-Knowledge Proof Generation for Trusted Execution Environments · Patent Pending · App. 19/684,949 · Filed May 22, 2026
INTELBIRD Cryptographic Architecture for Multi-Source Threat Intelligence Fusion with Hardware-Bound Verification and Byzantine Consensus · Patent Pending · App. 64/069,823 · Filed May 19, 2026
ZKML Verifiable Threat Detection Draft Provisional · Zero-knowledge machine learning integration for verifiably secure threat detection pipelines.
HTS Cryogen-Free Superconducting Magnet Platform for Whole-Body MRI Patent Pending · Provisional application · Filed 2026
See the full public patent portfolio
From term sheet to conversation

A measured path from fit to diligence.

Draft term-sheet interest starts with a focused conversation. We use the early stages to understand the opportunity and the later stages to protect the technical record.

01 / FIT

Opportunity fit

Identify the relevant technology area and whether the conversation is about investment, licensing, or acquisition.

02 / QUALIFY

Brief qualification

Share your organization, role, commercial context, and the scope of the opportunity you want to explore.

03 / REVIEW

Direct team review

We review the fit directly with the Hypha Labs team and determine the right next conversation.

04 / DILIGENCE

NDA-gated diligence

Qualified diligence can lead to an investor or licensing discussion, with technical material shared in the appropriate context.

Public copy stays at the abstract and business-outcome level. Claim sets, system architecture, design material, sequences, and other confidential technical details are not published; those materials are released only under NDA during a qualified engagement.

Ways to engage

Choose the conversation that matches your mandate.

Investment & portfolio discussion

For investors and strategic operators evaluating selected assets, the broader portfolio, or a draft term-sheet path.

Start an investment conversation

Technology licensing

For teams evaluating a specific technology area and a direct licensing relationship with Hypha Labs.

Explore the HTS magnet path

Portfolio acquisition

For organizations exploring acquisition of an individual asset or a defined portion of the public portfolio.

Discuss acquisition scope

When you contact us, include your organization, role, technology area, and whether you are exploring investment, licensing, or acquisition. The existing contact form can route the conversation using that context and a relevant subject.

Next step

Bring us the opportunity you are trying to evaluate.

Tell us what you are exploring and we will determine whether there is a focused path to review.

Discuss an Opportunity View the Patent Portfolio